Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State creates new oversight offices for drugs and health‑resource planning; HPC and CHIA seek staff and funding to implement mandates
Summary
The Health Policy Commission and CHIA told the Joint Committee on Ways and Means that two new laws expand their authority to analyze pharmaceutical pricing, private‑equity influence and the state’s health‑resource needs, and that modest budget increases are required to implement the mandates.
David Seltz, executive director of the Health Policy Commission (HPC), and Lauren Peters, executive director of the Center for Health Information and Analysis (CHIA), told the Joint Committee on Ways and Means that the legislature’s recent healthcare legislation significantly expands both agencies’ missions and will require modest additional resources to implement.
New responsibilities at a glance - Pharmaceutical analysis and transparency: Seltz said the law creates an Office of Pharmaceutical Policy and Analysis (OPA) within HPC to examine the full drug supply chain — manufacturers, PBMs, wholesalers and pharmacies — with fresh data and policy analysis. The office will advise state purchasers (MassHealth, Group Insurance Commission) and policymakers and aims to produce objective, system‑wide facts about pricing and flows.
- Health resource planning: The legislation creates an Office of Health Resource Planning…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
